Protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) mutations in haematological cancer
- 8 December 2020
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 192 (4) , 697-705
Abstract
Summary: Until recently, the protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) gene had not been examined in haematological cancer, but several studies have now explored the functional role of this gene and its aberrations. It is often mutated in the context of clonal haemopoiesis (including in patients with lymphoma, myeloproliferative neoplasms and myelodysplastic syndrome) and mutations have been associated with exposure to cytotoxic and radiation therapy, development of therapy‐related neoplasms and inferior survival. The vast majority of PPM1D mutations found in haematopoietic cells are of the nonsense or frameshift type and located within terminal exon 6. These genetic defects are rarely found in the blood of healthy individuals. PPM1D encodes the PPM1D phosphatase [also named wild‐type p53‐induced phosphatase 1 (WIP1)], which negatively regulates signalling molecules within the DNA damage response pathway, including tumour suppressor p53. Clonal expansion of PPM1D mutant haematopoietic cells can potentially be prevented with inhibitors; however, human trials are awaited. In the present review, we provide a review of the literature regarding PPM1D and its role in haematological cancer.Keywords
Funding Information
- Kræftens Bekæmpelse (R223‐A13071)
This publication has 60 references indexed in Scilit:
- Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpointJournal of Cell Biology, 2013
- Wip1 Directly Dephosphorylates γ-H2AX and Attenuates the DNA Damage ResponseCancer Research, 2010
- Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage ResponseCancer Research, 2009
- Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sitesNucleic Acids Research, 2008
- The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathwaysCancer and Metastasis Reviews, 2008
- The Wip1 Phosphatase Acts as a Gatekeeper in the p53-Mdm2 Autoregulatory LoopCancer Cell, 2007
- Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphataseJournal of Experimental Medicine, 2006
- The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesisOncogene, 2006
- Augmented cancer resistance and DNA damage response phenotypes in PPM1D null miceMolecular Carcinogenesis, 2006
- Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphataseCell Death & Differentiation, 2005